Daewoong Pharmaceutical Hosts 'NABOTA Master Class,' Highlighting Safety

74 Medical Professionals from 13 Countries Attend

Daewoong Pharmaceutical announced on the 16th that it successfully hosted the global academic program 'NABOTA Master Class (NMC) Spring in Korea.' The event took place over three days from April 13 to 15, gathering 74 medical professionals from 13 countries, including Thailand, Brazil, and Chile, at venues such as Mercure Seoul Magok, COEX Magok, Ewha Womans University Seoul Hospital, and Daewoong Pharmaceutical’s Hyangnam Plant.

NMC is an educational platform operated by Daewoong Pharmaceutical to strengthen the capabilities of medical professionals and promote academic exchange in response to the growing demand in the global botulinum toxin market. At this NMC, Daewoong Pharmaceutical focused on highlighting the safety and competitive quality of NABOTA from multiple angles, under the brand message “SAFETY ON, BEAUTY ON,” through both academic programs and production facility tours. As toxin procedures are shifting toward higher doses and regular treatments, product safety that remains consistent in such environments is emerging as a key criterion.

Medical professionals participating in 'NMC Spring in Korea,' hosted by Daewoong Pharmaceutical starting from the 13th of this month, are taking a group photo. Daewoong Pharmaceutical

The theoretical lecture session held on the first day of the event was organized around the theme of “Evidence & Safety.” The diverse program included: ▲ Dr. Choi Ho-sung of Rieul Dermatology Clinic on global trends and the latest injection techniques and safety of botulinum toxin aesthetic procedures; ▲ Dr. Choi Won-woo of Wells Dermatology Clinic on spread and persistence of different toxins based on global data; ▲ Dr. Jeong Jae-yoon of Oaro Dermatology Clinic, Nowon Branch on synergy combination procedures and real clinical applications using NABOLIFT, NABOGLOW, and calcium hydroxylapatite (CaHA); followed by ▲ a global session sharing trends in procedures and clinical cases by global KOLs, moderated by Dr. Yoon Chun-sik of Yemione Dermatology Clinic.

One of the key differentiators of this event was the anatomy session, designed to practically enhance the accuracy and safety of botulinum toxin injection procedures. Professor Han Seung-ho of Ewha Womans University Seoul Hospital, who previously served as Vice President of the International Federation of Associations of Anatomists, provided anatomy education using cadavers and a face painting session to explain facial anatomical structures and injection points by layer. This was followed by a live demonstration of NABOLIFT and NABOGLOW, as well as one-on-one hands-on training in groups. Eight speakers, including Dr. Noh Sung-min of Benjamin Dermatology Clinic, Dr. Guk Ji-soo of It’s Me Ansan, Dr. Bae Gyeong-tae of It’s Me Sejong, Dr. Park Young-woon of Villadskin Dermatology Clinic, and Dr. Jang Hyo-seung of Pierbom Clinic Gangnam, participated and received positive feedback for providing a highly focused program that connected experiential learning with real-world application.

In particular, NABOLIFT and NABOGLOW, signature procedures of NABOTA, have attracted consistent interest from medical professionals both in Korea and abroad. The session sharing practical clinical know-how and experience applicable in actual clinical settings received an enthusiastic response. “NABOLIFT” is known as a procedure that maximizes lifting and contouring focused on the muscle layer, while “NABOGLOW” targets improvements in skin texture, tone, and pores by focusing on the dermal layer.

Dr. Hardiono Tedy Saputra of Rejuvenated Clinic in Indonesia, who attended the event, commented, “This program was meaningful in that it went beyond simple procedural demonstrations to share specific techniques and know-how that can be immediately applied in clinical practice. In particular, the organically structured live demonstrations and hands-on training helped deepen my understanding of the procedures.”

The tour of Daewoong Pharmaceutical’s Hyangnam Plant was also one of the main programs. Medical professionals toured major facilities of both the existing and new plants, directly checking NABOTA’s quality management system and production infrastructure. By experiencing the aseptic processes, key production facilities, and automated logistics systems, participants confirmed the manufacturing competitiveness that underpins NABOTA’s safety and reliability.

Yoon Joonsoo, Head of the NABOTA Business Division at Daewoong Pharmaceutical, stated, “The key feature of this NMC was that NABOTA’s core value of ‘safety’ was consistently reflected throughout the event and curriculum, allowing global medical professionals to experience it firsthand. Moving forward, Daewoong Pharmaceutical will continue to strengthen its brand competitiveness and global leadership by spreading NABOTA’s unique procedures and clinical experience through a differentiated global academic platform.”

This content was produced with the assistance of AI translation services.